Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - amlodipine besilate 6,94 mg - eq. amlodipine 5 mg - tablet - 5 mg - amlodipine besilate - amlodipine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - amlodipine besilate 13,88 mg - eq. amlodipine 10 mg - tablet - 10 mg - amlodipine besilate - amlodipine

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.9 mg; hydrochlorothiazide, quantity: 12.5 mg; olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; povidone; pregelatinised maize starch; silicified microcrystalline cellulose; isopropyl alcohol; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - apo-olmesartan/amlodipine/hctz 40/10/12.5 mg is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination. this fixed dose combination is not indicated for initial therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.9 mg; hydrochlorothiazide, quantity: 25 mg; olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: isopropyl alcohol; silicified microcrystalline cellulose; povidone; lactose monohydrate; pregelatinised maize starch; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - apo-olmesartan/amlodipine/hctz 40/10/25 mg is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination. this fixed dose combination is not indicated for initial therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: colloidal anhydrous silica; croscarmellose sodium; microcrystalline cellulose; magnesium stearate - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Namibia - English - Namibia Medicines Regulatory Council

aurobindo pharma (pty) ltd - amlodipine besilate - tablet - each tablet contains amlodipine besilate equivalent to amlodipine 5,0 mg

Namibia - English - Namibia Medicines Regulatory Council

aurobindo pharma (pty) ltd - amlodipine besilate - tablet - each tablet contains amlodipine besilate equivalent to amlodipine 10,0 mg

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - amlodipine besilate 6.94mg equivalent to amlodipine 5 mg;  ; hydrochlorothiazide 12.5mg;  ;  ; valsartan 160mg;  ;  ;  ;   - film coated tablet - 5/160/12.5mg - active: amlodipine besilate 6.94mg equivalent to amlodipine 5 mg   hydrochlorothiazide 12.5mg     valsartan 160mg         excipient: colloidal silicon dioxide crospovidone magnesium stearate microcrystalline cellulose opadry white 00f18296 - exforge hct is indicated only as substitution therapy for the treatment of hypertension in patients whose blood pressure is already adequately controlled on the triple combination of amlodipine, valsartan and hydrochlorothiazide taken either as three single component formulations or as dual component formulation with a single component formulation, all components at the same dose level. treatment should not be initiated with these fixed-dose combinations.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - amlodipine besilate 6.94mg equivalent to amlodipine 5 mg;  ; hydrochlorothiazide 25mg;  ;  ; valsartan 160mg;  ;  ;  ;   - film coated tablet - 5/160/25mg - active: amlodipine besilate 6.94mg equivalent to amlodipine 5 mg   hydrochlorothiazide 25mg     valsartan 160mg         excipient: colloidal silicon dioxide crospovidone magnesium stearate microcrystalline cellulose opadry white 00f18296 opadry yellow 00f12951 - exforge hct is indicated only as substitution therapy for the treatment of hypertension in patients whose blood pressure is already adequately controlled on the triple combination of amlodipine, valsartan and hydrochlorothiazide taken either as three single component formulations or as dual component formulation with a single component formulation, all components at the same dose level. treatment should not be initiated with these fixed-dose combinations.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet - excipient ingredients: magnesium stearate; silicon dioxide; calcium phosphate; microcrystalline cellulose; sodium starch glycollate type a - hypertension,alkem amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of alkem amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent or an angiotensin-converting enzyme inhibitor.,angina,alkem amlodipine is indicated for the first line treatment of chronic stable angina. alkem amlodipine may be used alone, as monotherapy or in combination with other antianginal drugs.